New Alzheimer's treatment Reminyl™(galantamine) completes EU mutual recognition procedure

Beerse, Belgium, 12 July 2000 -- Reminyl™ (galantamine), a new treatment for Alzheimer's disease, was granted marketing approval under the Mutual Recognition Procedure by thirteen European Union member states as well as Norway and Iceland.

The countries mutually agreed to recognise the March approval of Reminyl™ (galantamine) by the Reference Member State, Sweden. Switzerland also received approval in June, following a separate application.

Novel Dual Mode of Action

Research indicates that Reminyl™ (galantamine), unlike other Alzheimer's treatments currently available, has a dual mechanism of action. Decreased levels of acetylcholine, caused by the death of acetylcholine neurones are known to be related to the symptoms of Alzheimer's disease. In addition to preserving levels of acetylcholine in the brain by blocking the action of the enzyme acetylcholinesterase (which inactivates acetylcholine), laboratory research has shown that Reminyl™ (galantamine) also appears to act on the brain's nicotinic receptors. The "modulation" of these receptors could lead to release of more acetylcholine. *1,2,3

Two phase III studies published this month in Neurology showed that treatment with Reminyl™ (galantamine) significantly improves cognition, global function and behavioural symptoms of Alzheimer's disease over a period of 1 year *4,5.

Reminyl™ (galantamine) is being developed by Janssen Pharmaceutica under a co-development agreement with UK-based Shire Pharmaceuticals Group plc.

"Reminyl™(galantamine) can improve patient's cognition including language and memory and preserves the ability to perform daily tasks. These improvements are crucial to physicians, patients and caregivers alike. We are hopeful that this approval will make this new option treatment option accessible to many more patients in need," said Dr Alain Raoult, Vice President, Global Product Leader, CNS R&D, Janssen Research Foundation.


Contact: Tamsin Page

Page: 1

Related medicine news :

1. Chemical decoy shows promise for slowing Alzheimers by acting as decoy
2. Neuronal death and processing of Tau protein in Alzheimers disease
3. Researchers discover link between insulin and Alzheimers
4. New trials for counseling caregivers and patients with Alzheimers begin
5. Marijuana ingredient may stall decline from Alzheimers
6. Drugs used to treat Alzheimers in nursing homes are worsening sufferers illness
7. UT Southwestern doctors track Oklahoma Alzheimers patients via telemedicine
8. Contrary to previous findings, smoking is detrimental to patients with Alzheimers
9. Nanoscale diagnostic sets sights on Alzheimers
10. New test is first step in early detection of Alzheimers disease
11. Older people with the Alzheimers gene find it harder to remember to remember even if healthy

Post Your Comments:

(Date:2/26/2020)... ... February 26, 2020 , ... ... 1pm EST with featured speaker Cristian Ionescu-Zanetti, PhD, Chief Technology Officer, Fluxion Biosciences ... IsoFlux system is a bench-top solution for high-sensitivity circulating tumor cell (CTC) enrichment ...
(Date:2/26/2020)... ... February 26, 2020 , ... ... the launch of its new HealthBus Worklflows solution, which will be showcased at ... deploying of client-specific health data exchange workflows to scenarios in days using a ...
(Date:2/23/2020)... ... February 22, 2020 , ... Although many people thrive on ... reveals that some people who dismiss compliments struggle with their sense of ... who took the Emotional Intelligence Test, Queendom researchers focused on two ...
(Date:2/21/2020)... (PRWEB) , ... February 21, 2020 , ... ... that it is now offering a 10 percent grand opening discount 0n its ... percent off all purchases," said Osmay Gonzalez, spokesperson for Baby Blendy LLC, a ...
(Date:2/21/2020)... ... February 21, 2020 , ... Used for years as a ... traction as a viable replacement for invasive cosmetic surgery, such as breast augmentation. ... remain the market leader for the expected robust growth of autologous fat grafting ...
Breaking Medicine News(10 mins):
(Date:2/28/2020)... ... February 28, 2020 , ... At the very heart of ... no deterent to mandatory attendance in crowded conditions at the church in Daegu, South ... with the disease. , In America, we too have our gathering places where one ...
(Date:2/28/2020)... ... February 28, 2020 , ... Jason Colleran, Founder of The Perfect ... throwing support sleeve. The Perfect Arm product made its first appearance last January at ... and won “Best of Show” for the most innovative baseball product. , This company ...
(Date:2/28/2020)... (PRWEB) , ... February 27, 2020 , ... This Women’s ... history with VA. , “For the Department of Veterans Affairs, Women’s History Month ... proud of the role we play in the remaining chapters of their story,” said ...
Breaking Medicine Technology:
Cached News: